Dr. Schechtman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6818 W Thunderbird Rd
Peoria, AZ 85381Phone+1 623-209-7831Fax+1 623-566-3573
Education & Training
Cleveland Clinic FoundationFellowship, Rheumatology, 1983 - 1985
Ohio University Heritage College of Osteopathic Medicine in AthensClass of 1980
Certifications & Licensure
OH State License 1981 - 2026
AZ State License 1987 - 2025
IL State License 1985 - 1990
TN State License 1980 - 1989
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Top MD Consumers Checkbook
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study Start of enrollment: 2006 Mar 01
- Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee Start of enrollment: 2006 Mar 01
- An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
- Join now to see all
Publications & Presentations
PubMed
- 285 citationsAnakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-co...Roy M. Fleischmann, Joy Schechtman, Ralph Bennett, Malcolm L. Handel, Gerd-Rüdiger Burmester
Arthritis and Rheumatism. 2003-04-01 - 759 citationsThe efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, plac...Paul Emery, Roy Fleischmann, Anna Filipowicz-Sosnowska, Joy Schechtman, Leszek Szczepanski
Arthritis and Rheumatism. 2006-05-01 - 152 citationsOcrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, d...Mark C. Genovese, Jeffrey L. Kaine, Mitchell B. Lowenstein, Jose Del Giudice, Andrew R. Baldassare
Arthritis and Rheumatism. 2008-09-01
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
